p.23.0459916

proceeding

ACT_459916/2023 UPC_CFI_14/2023

ACT_459916/2023 - Infringement Action

2023

Munich Local Division - First Instance

Date of Filing: 26/06/23

Registry Numbers: ACT_459916/2023 UPC_CFI_14/2023

Case Title:

Patents

EP3666797

Patents

EP3666797

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Parties

Claimant 1. Amgen Inc.

Defendant 2. Sanofi-Aventis Deutschland GmbH

Defendant 3. Sanofi-Aventis Groupe S.A.

Defendant 4. Sanofi Winthrop Industrie S.A.

Defendant 5. Regeneron Pharmaceuticals Inc.